MUC4 and cholangiocarcinoma: In univariate analysis, CCA patients undergoing chemotherapy with high expressions of MUC4 or lung metastasis had an inferior PFS compared with that of CCA patients with low MUC4 expression or without lung metastasis (Table 1).